Proatherogenic pathways leading to vascular calcification.
Cardiovascular disease is the leading cause of morbidity and mortality in the western world and atherosclerosis is the major common underlying disease. The pathogenesis of atherosclerosis involves local vascular injury, inflammation and oxidative stress as well as vascular calcification. Vascular calcification has long been regarded as a degenerative process leading to mineral deposition in the vascular wall characteristic for late stages of atherosclerosis. However, recent studies identified vascular calcification in early stages of atherosclerosis and its occurrence has been linked to clinical events in patients with cardiovascular disease. Its degree correlates with local vascular inflammation and with the overall impact and the progression of atherosclerosis. Over the last decade, diverse and highly regulated molecular signaling cascades controlling vascular calcification have been described. Local and circulating molecules such as osteopontin, osteoprogerin, leptin and matrix Gla protein were identified as critical regulators of vascular calcification. We here review the current knowledge on molecular pathways of vascular calcification and their relevance for the progression of cardiovascular disease.
Mazzini
Michael J
MJ
Department of Cardiology, Boston University Medical Center, Boston, MA 02118-2526, USA.
Schulze
P Christian
PC
D002114:Calcinosis / Q000209:etiology*; D003324:Coronary Artery Disease / Q000209:etiology*; D006801:Humans; D020738:Leptin / Q000378:metabolism; D011506:Proteins / Q000378:metabolism; D014812:Vitamin K / Q000378:metabolism
D020738:Leptin; D011506:Proteins; D014812:Vitamin K